Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Simcere Pharmaceutical Group Limited ( (HK:2096) ) has shared an announcement.
Simcere Pharmaceutical Group Limited announced a supplemental update regarding its connected transaction involving the acquisition of assets from Sanroad Shanghai and the entire equity interest in Xianwei. This strategic move is expected to enhance Simcere’s operational capabilities and market positioning by expanding its asset base and potentially increasing its influence in the pharmaceutical sector.
More about Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. The company focuses on the development, production, and distribution of pharmaceutical products, with a market presence that spans various therapeutic areas.
Average Trading Volume: 23,125,103
Technical Sentiment Signal: Buy
Current Market Cap: HK$33.95B
Find detailed analytics on 2096 stock on TipRanks’ Stock Analysis page.